Endocrinology and Metabolic Diseases

Doç. Dr. Sinan Tanyolaç

Doctor and researcher Medicana Çamlıca İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.

  • Diabetes Mellitus (Tip 1 ve Tip 2) – insülin yönetimi ve ileri tedavi protokolleri dahil
  • Obezite ve Metabolik Sendrom
  • Tiroid Bozuklukları
  • Lipid ve Lipid Metabolizması Bozuklukları
  • Hipofiz ve Adrenal Bozuklukları
  • Metabolik Kemik Hastalığı
  • Hormonal Yönetim ve Replasman Tedavileri

CV

Education and experience

From source

Experience

  • 2026-HalenMedicana Çamlıca Hastanesimedicana.com.tr
  • 2025Beykent Üniversitesimedicana.com.tr
  • 2023-2024Biruni Üniversitesimedicana.com.tr
  • 2017-2018Aydın Üniversitesimedicana.com.tr

Education

  • 1995İstanbul Üniversitesi Tıp Fakültesimedicana.com.tr
  • 2001İstanbul Üniversitesimedicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyEndocrinology and Metabolic Diseasesmedicana.com.trFrom source
  • InstitutionMedicana Çamlıcamedicana.com.trFrom source
  • Publications17 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:26https://www.medicana.com.tr/hekim-detay/27991/sinan-tanyolacmedicana.com.tr

Scientific work

Publications

17 publications

  1. Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)

    Source: medicana.com.tr profile page

  2. Exocrine Pancreatic Insufficiency in Diabetes: Association with Cardiovascular Disease and Insulin Therapy. Balamir M, Tanyolaç S, et al. J Clin Med. 2026;15(4):1023. doi: 10.3390/jcm15041023.

    Source: medicana.com.tr profile page

  3. Insulin Resistance and Cancer: In Search for a Causal Link. Chiefari E, Tanyolaç S, et al. Int J Mol Sci. 2021 Oct 15;22(20):11137. doi: 10.3390/ijms222011137.

    Source: medicana.com.tr profile page

  4. Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes. Mirabelli M, Chiefari E, Caroleo P, Arcidiacono B, Corigliano DM, Giuliano S, Brunetti FS, Tanyolaç S, Foti DP, Puccio L, Brunetti A. Int J Environ Res Public Health. 2019 Dec 27;17(1):207. doi: 10.3390/ijerph17010207.

    Source: medicana.com.tr profile page

  5. Evidence that an HMGA1 gene variant associates with type 2 diabetes, BMI, and HDL cholesterol in a Hispanic-American population. Pullinger CR, Goldfine ID, Tanyolac S, et.al. Metab Syndr Relat Disord. 2014;12(1):25-30. doi: 10.1089/met.2013.0086.

    Source: medicana.com.tr profile page

  6. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Chiefari E, Tanyolaç S, Iiritano S, et.al. Sci Rep. 2013;20(3):1491.

    Source: medicana.com.tr profile page

  7. Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530. Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, Goldfine ID. Diabetes. 2012 May;61(5):e3. doi: 10.2337/db12-0051.

    Source: medicana.com.tr profile page

  8. Bonnefond A, Lomberk G, Buttar N, Busiah K, Vaillant E, Lobbens S, Yengo L, Dechaume A, Mignot B, Simon A, Scharfmann R, Neve B, Tanyolaç S, Hodoglugil U, Pattou F, Cavé H, Iovanna J, Stein R, Polak M, Vaxillaire M, Froguel P, Urrutia R. "Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus." J Biol Chem. 2011 Aug 12;286(32):28414-24.

    Source: medicana.com.tr profile page

  9. Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, Goldfine ID. "Low Frequency Variants in HMGA1 are associated with Type 2 Diabetes." Diabetes. 2012 May;61(5):e3.

    Source: medicana.com.tr profile page

  10. Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, Iiritano S, Mazza T, Forlin M, Fusco A, Durlach V, Durlach A, Malloy MJ, Kane JP, Heiner SW, Filocamo M, Foti DP, Goldfine ID, Brunetti A. "Functional variants of the HMGA1 gene and type 2 diabetes mellitus." JAMA. 2011 Mar;305(9):903-912.

    Source: medicana.com.tr profile page

View all 17 publications